Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Co-Chief Executive Officer, Director
-
Stock Symbol
-
AMLX on Nasdaq
Justin B. Klee - trading volume in the past year for Amylyx Pharmaceuticals, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
3.2M |
$5.03M |
$1.57 |
Feb 5, 2025 |
Direct |
|
|
Stock Option (right to buy) |
0 |
|
|
Feb 5, 2025 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.